vaccine-manufacturing
35 Results
Búsqueda avanzada
Mostrar
-
-
Press Release: Merck Joins DiViNe Consortium to Address Low Yields, High Costs of Vaccine Purification Processes
Merck has joined the DiViNe project, a European consortium of six companies to address the biggest challenges facing the development, manufacture and delivery of vaccines. -
Press Release: Merck to Develop Next-Generation Purification Processes with International Vaccine Institute
Merck has entered a research agreement with the International Vaccine Institute (IVI) of Seoul, South Korea to help develop more robust, scalable vaccine manufacturing processes. -
Press Release: Merck Helps Accelerate Global Access to Affordable Vaccines
Merck today announced a partnership with Oxford University's Jenner Institute to develop more robust and scalable vaccine manufacturing processes. -
Press Release: Merck to Acquire Natrix Separations to Advance Next-Generation Processing Capabilities
Merck today announced that it has entered into an agreement to acquire Natrix Separations, an Ontario, Canada-based provider of hydrogel membrane products for single-use chromatography. -
Press Release: Merck and Baylor College of Medicine Advance Vaccine Development and Manufacturing for Neglected Diseases
Merck today announced that it has formed a strategic alliance with Baylor College of Medicine (Texas, U.S.) and its vaccine product development partnership (PDP), Texas Children's Hospital Center for Vaccine Development... -
Biopharmaceutical Manufacturing Products | Merck
We support you at all stages of the biopharmaceutical manufacturing process from accelerating time to market to mitigating production risks and cutting costs. -
About Our Brands | About Us | Merck
Merck brings together 6 of the world's leading Life Science brands to help you solve your toughest problems in life science. -
Lipids for pharmaceutical applications | Small Molecule Pharmaceuticals | Merck
As a highly specialized manufacturer of novel excipients, Merck focuses on the tailored manufacturing of synthetic lipids for our customers. -
Event | Plasma Product Biotechnology Meeting 2019 | Merck
The Plasma Product Biotechnology Conference Series provides a valuable opportunity to discuss topics relevant to the plasma fractionation industry including manufacturing, quality, regulatory, pathogen safety, clinical development and technical innovations.